With “Connecting Bridge” the H.U.B aims to combat the isolation of patients with psychiatric problems.
Congenital heart disease: continuity of care, from childhood to adulthood, is a vital necessity for patients
Aphinity trial: New Progress in the treatment of HER2-positive breast cancer
A world first at the H.U.B in treating cerebral vascular malformations in newborns.
The H.U.B is proposing a special day for heart failure screening complete with an innovative test
A total immersion at Brussels University Hospital to attract new talent
Fast-track diagnosis for colorectal cancer at the H.U.B
Brussels, 12/17/2024 – The Jules Bordet Institute is taking a major step forward in becoming one of just 12 centres worldwide to incorporate Comprehensive Motion Management (CMM) in its MR-Linac, a technology at the forefront of radiotherapy.
Brussels, 18 November 2024 – As part of Movember, a month dedicated to raising awareness of men’s health, the Jules Bordet Institute is organising the “Bring your balls” event on Monday 25th November. An invitation for men, both young and not so young, to find out more about men’s health in a relaxed and friendly atmosphere over a game of pétanque. This unique event aims to encourage men to open up and freely discuss health issues on which they too often remain silent: men’s mental health, the side effects of male cancers, and prevention. The concept originated in a unique collaboration between care staff and patients who also want to break taboos.
In November, “Bordet is pulling out all the stops”. In launching this campaign, the H.U.B care teams are seeking to increase awareness and encourage discussion of male cancers. With the fear of losing their masculinity and a sense of shame or embarrassment in talking about it, men rarely dare open up about their physical or mental health. Yet they are also at risk of being affected by cancer at some point in their lives. Removing taboos and opening up about the disease are nonetheless essential when you consider that the earlier a cancer is detected the greater the chances of remission. At the Jules Bordet Institute, which is a part of the Brussels University Hospital (H.U.B), each patient receives global and personalised care adapted to their pathology, from detection through to treatment and post-cancer monitoring. The expertise of the multidisciplinary teams combined with the state-of-the-art technology provide the best guarantees of maintaining the patient’s quality of life.
A EUR 16 million Initiative to Establish Strategic EU Autonomy in Alpha Therapies for
By clicking "Subscribe" I confirm I have read and agree to the Privacy Policy.
